7Baggers

Lixte Biotechnology Quarterly Balance Sheets Chart

Quarterly
 | 
Annual
 
 Current Account Receivables  
 Current Account Payables  
20190331 20190630 20190930 20191231 20200331 20200630 20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 053.24106.49159.73212.98266.22319.46372.71Thousand

Lixte Biotechnology Quarterly Balance Sheets Table

Quarterly
 | 
Annual
 
Unit: USD2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 
  current account reveivables285 14,367 21,974 17,071 4,161 
  current account payables156,758 221,171 366,528 223,631 229,764 307,398 372,708 225,965 232,016 162,447 148,871 190,292 115,518 189,868 160,927 143,549 273,533 183,882 210,673 

We provide you with 20 years of balance sheets for Lixte Biotechnology stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Lixte Biotechnology. Explore the full financial landscape of Lixte Biotechnology stock with our expertly curated balance sheets.

The information provided in this report about Lixte Biotechnology stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.